Cohen Lawrence B Gilead Sciences, Inc. Transaction History

Cohen Lawrence B

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $14,788 - $16,134	-200 Reduced 0.95%	20,750 $1.56 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $5,656 - $6,460	-95 Reduced 0.45%	20,950 $1.29 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $1,390 - $1,741	-24 Reduced 0.11%	21,045 $1.25 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $1,557 - $1,767	24 Added 0.11%	21,069 $1.53 Million
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $3,722 - $4,016	-55 Reduced 0.26%	21,045 $1.47 Million
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $9,394 - $12,033	-150 Reduced 0.71%	21,100 $1.58 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $9,376 - $10,350	-150 Reduced 0.7%	21,250 $1.35 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $9,379 - $10,507	-150 Reduced 0.7%	21,400 $1.39 Million
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $89,100 - $98,650	-1,250 Reduced 5.48%	21,550 $1.66 Million
Q1 2018 Apr 19, 2018	SELL	$72.84 - $88.8 $18,210 - $22,200	-250 Reduced 1.08%	22,800 $1.72 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $1.66 Million - $1.97 Million	23,050	23,050 $1.87 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

Stay updated on Cohen Lawrence B with notifications on news.